7 genomic sequencing mandates transforming clinical oncology in 2026
As we navigate through 2026, the global healthcare sector is witnessing a mandatory transition toward comprehensive genomic profiling for all stage-three cancer diagnoses. This regulatory shift, spearheaded by the European Medicines Agency and the US FDA, aims to eliminate the "trial-and-error" approach in chemotherapy. By...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
Spanish 
thai
English
French
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china